Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John Varga

Showing results (271-280 of 297) with videos related to

Pageof 30
Sort By:
The Journal of Investigative Dermatology|December 17, 2022
Mindin (SPON2) Is Essential for Cutaneous Fibrogenesis in a Mouse Model of Systemic SclerosisIsha Rana, Sunny Kataria, Tuan Lin Tan, et al.
Arthritis and Rheumatism|May 1, 2007
Impact of oral cyclophosphamide on health-related quality of life in patients with active scleroderma lung disease: results from the scleroderma lung studyDinesh Khanna, Xiaohong Yan, Donald P Tashkin, et al.
The Lancet. Rheumatology|April 26, 2021
Effects of a multi-faceted education and support programme on anxiety symptoms among people with systemic sclerosis and anxiety during COVID-19 (SPIN-CHAT): a two-arm parallel, partially nested, randomised, controlled trialBrett D Thombs, Linda Kwakkenbos, Brooke Levis, et al.
Medrxiv : the Preprint Server for Health Sciences|June 12, 2025
Machine Learning Analysis of Electronic Health Records Identifies Interstitial Lung Disease and Predicts Mortality in Patients with Systemic SclerosisAlec K Peltekian, Kevin M Grudzinski, Bradford C Bemiss, et al.
Clinical and Experimental Rheumatology|December 3, 2016
Utility of B-type natriuretic peptides in the assessment of patients with systemic sclerosis-associated pulmonary hypertension in the PHAROS registryLorinda Chung, Robert M Fairchild, Daniel E Furst, et al.
Medicine|February 3, 2018
Clinical and serological features of systemic sclerosis in a multicenter African American cohort: Analysis of the genome research in African American scleroderma patients clinical databaseNadia D Morgan, Ami A Shah, Maureen D Mayes, et al.
Journal of Clinical Epidemiology|April 12, 2014
Multicriteria decision analysis methods with 1000Minds for developing systemic sclerosis classification criteriaSindhu R Johnson, Raymond P Naden, Jaap Fransen, et al.
American Journal of Respiratory and Critical Care Medicine|August 25, 2007
Effects of 1-year treatment with cyclophosphamide on outcomes at 2 years in scleroderma lung diseaseDonald P Tashkin, Robert Elashoff, Philip J Clements, et al.
Seminars in Arthritis and Rheumatism|January 13, 2015
Antinuclear antibody-negative systemic sclerosisGloria A Salazar, Shervin Assassi, Fredrick Wigley, et al.
Genome Research|July 11, 2006
Skewed genomic variability in strains of the toxigenic bacterial pathogen, Clostridium perfringensGarry S A Myers, David A Rasko, Jackie K Cheung, et al.
Pageof 30

Showing results (271-280 of 297) with videos related to

Sort By:
Pageof 30
The Journal of Investigative Dermatology|December 17, 2022
Mindin (SPON2) Is Essential for Cutaneous Fibrogenesis in a Mouse Model of Systemic SclerosisIsha Rana, Sunny Kataria, Tuan Lin Tan, et al.
Arthritis and Rheumatism|May 1, 2007
Impact of oral cyclophosphamide on health-related quality of life in patients with active scleroderma lung disease: results from the scleroderma lung studyDinesh Khanna, Xiaohong Yan, Donald P Tashkin, et al.
The Lancet. Rheumatology|April 26, 2021
Effects of a multi-faceted education and support programme on anxiety symptoms among people with systemic sclerosis and anxiety during COVID-19 (SPIN-CHAT): a two-arm parallel, partially nested, randomised, controlled trialBrett D Thombs, Linda Kwakkenbos, Brooke Levis, et al.
Medrxiv : the Preprint Server for Health Sciences|June 12, 2025
Machine Learning Analysis of Electronic Health Records Identifies Interstitial Lung Disease and Predicts Mortality in Patients with Systemic SclerosisAlec K Peltekian, Kevin M Grudzinski, Bradford C Bemiss, et al.
Clinical and Experimental Rheumatology|December 3, 2016
Utility of B-type natriuretic peptides in the assessment of patients with systemic sclerosis-associated pulmonary hypertension in the PHAROS registryLorinda Chung, Robert M Fairchild, Daniel E Furst, et al.
Medicine|February 3, 2018
Clinical and serological features of systemic sclerosis in a multicenter African American cohort: Analysis of the genome research in African American scleroderma patients clinical databaseNadia D Morgan, Ami A Shah, Maureen D Mayes, et al.
Journal of Clinical Epidemiology|April 12, 2014
Multicriteria decision analysis methods with 1000Minds for developing systemic sclerosis classification criteriaSindhu R Johnson, Raymond P Naden, Jaap Fransen, et al.
American Journal of Respiratory and Critical Care Medicine|August 25, 2007
Effects of 1-year treatment with cyclophosphamide on outcomes at 2 years in scleroderma lung diseaseDonald P Tashkin, Robert Elashoff, Philip J Clements, et al.
Seminars in Arthritis and Rheumatism|January 13, 2015
Antinuclear antibody-negative systemic sclerosisGloria A Salazar, Shervin Assassi, Fredrick Wigley, et al.
Genome Research|July 11, 2006
Skewed genomic variability in strains of the toxigenic bacterial pathogen, Clostridium perfringensGarry S A Myers, David A Rasko, Jackie K Cheung, et al.
Pageof 30